HomeSAGE • NASDAQ
add
SAGE Therapeutics Inc
Previous close
$6.86
Day range
$6.78 - $7.09
Year range
$4.62 - $13.46
Market cap
427.39M USD
Avg Volume
1.22M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 14.06M | 77.97% |
Operating expense | 57.59M | 9.54% |
Net income | -62.21M | 42.65% |
Net profit margin | -442.39 | 67.78% |
Earnings per share | -1.00 | 44.58% |
EBITDA | -66.83M | 43.05% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 423.85M | -40.89% |
Total assets | 469.67M | -38.81% |
Total liabilities | 59.82M | -3.20% |
Total equity | 409.85M | — |
Shares outstanding | 62.62M | — |
Price to book | 1.05 | — |
Return on assets | -32.91% | — |
Return on capital | -37.25% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -62.21M | 42.65% |
Cash from operations | -81.73M | -116.03% |
Cash from investing | 45.78M | -67.17% |
Cash from financing | 148.00K | -90.49% |
Net change in cash | -35.80M | -134.70% |
Free cash flow | -60.87M | -6,937.98% |
About
Founded
2010
Website
Employees
353
